Additionally, MRPS11 and MRPS12 could potentially serve as therapeutic targets for the treatment of ischemic stroke, as mitochondrial dysfunction has been implicated in stroke pathophysiology. This evidence concerns the gene MRPS12 and ischemic stroke.